A federal appeals court declines to review its decision to overturn a lost profits award to Medtronic in its long-running patent infringement war with NuVasive.
Here's a look at some of the top legal news stories for medical device companies this week: Appeals court upholds NuVasive patent win over Medtronic; Appeals court won't revisit Bard's $1B win over W.L. Gore; Ex-Boston Scientific engineer cops to stealing catheter secrets; AngioDynamics wants court to enforce $160m Biolitec judgment
A federal appeals court deals a blow to Medtronic when it upholds the U.S. Patent & Trademark Office's decision to validate a patent held by NuVasive.
A federal appeals court yesterday dealt Medtronic (NYSE:MDT) a 2nd blow in nearly as many weeks when it upheld a U.S. Patent & Trademark Office decision that a NuVasive patent is valid.
NuVasive says it ousted 16-year CEO Alex Lukianov over violations of its expense and personnel policies, leading analysts to speculate that an acquisition is now more likely for the spinal implant maker.
UPDATED April 1, 2015, with analysts' comments, share performance.
Here's a look at some of the top legal news stories for medical device companies this week: St. Jude Medical settles Riata, shareholder suits for $64m; Appeals court overturns lost profits award in Medtronic's spat with NuVasive; Big medtech gets behind gay marriage; Bankrupt NuOrtho Surgical looks to liquidate; Boston Scientific must pay pacemaker replacement surgery: EU court
A federal appeals court overturns the lost profits awarded to Medtronic in its long-running patent infringement war with NuVasive.
NuVasive closes out 2014 with solid 4th-quarter results, but still posts a net loss for 2014, and misses analysts' expectations with its 2015 forecast.